These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26656302)

  • 1. Development of prilling process for biodegradable microspheres through experimental designs.
    Fabien V; Minh-Quan L; Michelle S; Guillaume B; Van-Thanh T; Marie-Claire VJ
    Int J Pharm; 2016 Feb; 498(1-2):96-109. PubMed ID: 26656302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of PLGA microparticles by an emulsion-extraction process using glycofurol as polymer solvent.
    Aubert-Pouëssel A; Venier-Julienne MC; Saulnier P; Sergent M; Benoît JP
    Pharm Res; 2004 Dec; 21(12):2384-91. PubMed ID: 15648273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of a novel bioactive glass/lysozyme/PLGA composite microsphere.
    Liu H; Shi S; Cao J; Ji L; He Y; Xi J
    Drug Dev Ind Pharm; 2015 Mar; 41(3):458-63. PubMed ID: 24471512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
    Yang Y; Gao Y; Mei X
    Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of PEG-PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers.
    Takami T; Murakami Y
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):433-8. PubMed ID: 21715147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step production of protein-loaded PLGA microparticles via spray drying using 3-fluid nozzle.
    Wan F; Maltesen MJ; Andersen SK; Bjerregaard S; Foged C; Rantanen J; Yang M
    Pharm Res; 2014 Aug; 31(8):1967-77. PubMed ID: 24549821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reproducible accelerated in vitro release testing method for PLGA microspheres.
    Shen J; Lee K; Choi S; Qu W; Wang Y; Burgess DJ
    Int J Pharm; 2016 Feb; 498(1-2):274-82. PubMed ID: 26705156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.
    Wang H; Jia Y; Hu W; Jiang H; Zhang J; Zhang L
    Pharm Dev Technol; 2013; 18(3):694-700. PubMed ID: 22676257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of polymeric particles in CO(2) medium using non-toxic solvents: formulation and comparisons with a phase separation method.
    Tran MK; Swed A; Boury F
    Eur J Pharm Biopharm; 2012 Nov; 82(3):498-507. PubMed ID: 22959993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres.
    Giteau A; Venier-Julienne MC; Marchal S; Courthaudon JL; Sergent M; Montero-Menei C; Verdier JM; Benoit JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):127-36. PubMed ID: 18448319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studies.
    Han B; Wang HT; Liu HY; Hong H; Lv W; Shang ZH
    Int J Pharm; 2010 Oct; 398(1-2):130-6. PubMed ID: 20688141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of improved structural integrity of protein in polymer based microsphere delivery system.
    Rawat S; Kohli N; Suri CR; Sahoo DK
    Mol Pharm; 2012 Sep; 9(9):2403-14. PubMed ID: 22724678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ethylene glycol) methacrylate hydrolyzable microspheres for transient vascular embolization.
    Louguet S; Verret V; Bédouet L; Servais E; Pascale F; Wassef M; Labarre D; Laurent A; Moine L
    Acta Biomater; 2014 Mar; 10(3):1194-205. PubMed ID: 24321348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical parameters involved in producing microspheres by prilling of molten lipids: from theoretical prediction of particle size to practice.
    Séquier F; Faivre V; Daste G; Renouard M; Lesieur S
    Eur J Pharm Biopharm; 2014 Aug; 87(3):530-40. PubMed ID: 24675371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.